Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

TELUS declares quarterly dividend of CAD 0.4184 per share payable July 2, 2026.

Company Fundamentals
08 May 2026
Andrea Wood, Executive Vice President And Chief Legal And Governance Officer
View Source
Neutral
pluang ai news

TELUS Corporation's Board of Directors has announced a quarterly dividend of 0.4184 Canadian dollars per common share. The dividend will be paid on July 2, 2026, to shareholders recorded by the close of business on June 10, 2026. This dividend reflects TELUS's ongoing commitment to returning value to its shareholders. Investors holding shares before the record date will be eligible for this payment.

More News

Globant shares jump 13% as AI-driven growth boosts Q1 revenue and share buyback plans.

Globant shares jump 13% as AI-driven growth boosts Q1 revenue and share buyback plans.

Globant reported Q1 adjusted EPS of $1.50, matching expectations, and revenue of $607.1 million, slightly above estimates. The company's AI Pods contributed significantly to growth, with annual recurring revenue reaching $32.8 million. Despite a slig...

Company Fundamentals
Bullish
1 hour ago
New Nasdaq rules could trigger $60B+ in SpaceX ETF buying right after IPO listing.

New Nasdaq rules could trigger $60B+ in SpaceX ETF buying right after IPO listing.

Former Goldman Sachs exec Chan Ahn highlights that Nasdaq's updated index-inclusion rules may lead to over $60 billion in institutional ETF buying of SpaceX shares soon after its IPO. This is due to a 'fast entry' rule allowing SpaceX to join the Nas...

Market News
Bullish
1 hour ago
Investigation launched into Alphatec Holdings over possible securities law violations after Q1 earnings miss.

Investigation launched into Alphatec Holdings over possible securities law violations after Q1 earnings miss.

Glancy Prongay Wolke & Rotter LLP has started a securities fraud investigation into Alphatec Holdings following the company's Q1 2026 earnings report, which missed revenue estimates and lowered its full-year outlook. Alphatec reported lower deliverie...

Market News
Bearish
2 hours ago
Cancer centers rush to enroll patients in Revolution Medicines' pancreatic cancer drug after positive trial results.

Cancer centers rush to enroll patients in Revolution Medicines' pancreatic cancer drug after positive trial results.

Revolution Medicines received FDA approval for an expanded access program for its pancreatic cancer drug, daraxonrasib, following positive Phase 3 trial results showing significant survival benefits. The drug demonstrated a median overall survival of...

Market News
Bullish
2 hours ago
SaintQuant launches AI crypto trading bots amid Bitcoin surge and rising institutional interest

SaintQuant launches AI crypto trading bots amid Bitcoin surge and rising institutional interest

SaintQuant has officially launched its AI-driven quantitative crypto trading platform, offering retail investors easy, no-code access to automated trading strategies. This launch coincides with Bitcoin surpassing $82,000 and record institutional infl...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App